Sonoma Pharmaceuticals Inc (SNOA) USD0.0001

Sell:$2.86Buy:$3.09$0.05 (1.71%)

Prices delayed by at least 15 minutes
Sell:$2.86
Buy:$3.09
Change:$0.05 (1.71%)
Prices delayed by at least 15 minutes
Sell:$2.86
Buy:$3.09
Change:$0.05 (1.71%)
Prices delayed by at least 15 minutes

Company Information

About this company

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Key people

Amy Trombly
Chief Executive Officer, Director
Jerry Dvonch
Chief Financial Officer
Bruce Thornton
Chief Operating Officer, Executive Vice President, Corporate Secretary
Jerry G. Mclaughlin
Lead Independent Director
Jay E. Birnbaum
Independent Director
Philippe Weigerstorfer
Independent Director
Click to see more

Key facts

  • EPIC
    SNOA
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US83558L3033
  • Market cap
    $4.80m
  • Employees
    168
  • Shares in issue
    1.64m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.